At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 28 enrolled
Drug / intervention
CG100649 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Open, Crossover Clinical Study to Investigate the Effects of Ketoconazole on the Pharmacokinetics of CG100649 in Healthy Male Volunteers
In Brief
A Phase 1 clinical trial evaluating CG100649 and Ketoconazole for Healthy. Completed, enrolled 28 participants across 1 site.
Detailed Summary
This is a Phase I, open-labeled, randomization and 2x2 Cross trial to compare the pharmacokinetic effects between ketoconazole and CG100649 for healthy male volunteers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesSouth Korea
Collaborators--
Timeline
Phase 1CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2009
Primary CompletionMar 2010
First PostedJul 2010
Study CompletionDec 2010
TodayJul 2026
First PostedJul 1, 2010
Enrollment StartOct 1, 2009
Primary CompletionMar 1, 2010
Study CompletionDec 1, 2010
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 16.0 years ago
Interventions
CG100649drug
I period: CG 100649 II period: Ketoconalzole + CG100649 at the same time
Ketoconazoledrug
I period: ketoconazole + CG100649 II period: CG 100649